Technical Description
A novel space filler material for post-cancer surgery. It is composed of 2D or 3D soft materials, like glycans, glycopolymers, and chitosan assemblies. The material supports the selective release of the drug-conjugated chitosan molecules, thereby limiting secondary metastasis and the recurrence of cancer cells after cancer surgery.
Problems Addressed
- Low Existing Treatment Efficacy
- Cancer Recurrence
- Lacks Polymeric Assembliess
- Lack of Effective Space Filler Materials
- Metastasis
- Cancer Cell Proliferation
- Allergic Reactions and Side Effects
Tech Features
- Antitumor Biomaterial
- Sustainable Drug Release
- Effective Primary Cancer Treatment
- Glycan & Glycopolymer Integration
- Flexibility & Morphological Variability
- Anti-Cancer Drug Conjugation
- 2D or 3D Polymeric Assemblies
- Limits Secondary Metastasis
- Prevents Cancer Recurrence
- Inhibits Cell Proliferation
Target Audience
- Pharmaceutical Industries
- Medical Device Industries
- Cancer Research
- Research and Development
Tech ID: 27-1155 TRL 3 Patent Status: Published Available For Exclusive and Non-exclusive License
